Hanmi's New Story
창조와 혁신, 도전
한미약품의 새로운 비상이 시작됩니다.
Meet Us at the Joint Congress of ESPE(European Society for Paediatric Endocrinology) and ESE(European Society of Endocrinology) 2025.
An Ongoing Phase 2 Study of Efpegerglucagon: Promising Results on Safety and Efficacy in Subjects with Congenital Hyperinsulinism
- Poster Number
- RC3.2a
- Session
- Poster section Fetal and Neonatal Endocrinology, Saturday, May 10 15:00 - 20:00 CEST/ Sunday, May 11 from 08:00 CEST, Poster Hall C
- Presenter
-
Antonia Dastamani / Great Ormond Street Hospital
Antonia.Dastamani@gosh.nhs.uk
An Ongoing Phase 2 Study of Efpegerglucagon: Promising Results on Safety and Efficacy in Subjects with Congenital Hyperinsulinism
- Presentation
- RC3.2
- Session
- Rapid Communications, Sunday, 11 May, 14:20 - 14:25 CEST, D5
- Presenter
-
Antonia Dastamani / Great Ormond Street Hospital
Antonia.Dastamani@gosh.nhs.uk
